21st Century Oncology Holdings Inc. IPO Research Information

21st Century Oncology Holdings Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on 21st Century Oncology Holdings Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
21st Century Oncology Holdings Inc.	ICC - NYSE	$8.00-$10.00	$0.00	$0.00	11.1 million	5/22/2014
Underwriter(s): Morgan Stanley, J.P. Morgan, Wells Fargo Securities
Co-Manager(s): SunTrust Robinson Humphrey, KeyBanc Capital Markets, Avondale Partners, Piper Jaffray
Industry:
Filing(s): Filed 2014-02-11 Terms Added 2014-05-07 Amended Terms 2014-05-21

About 21st Century Oncology Holdings Inc. (adapted from 21st Century Oncology Holdings Inc. prospectus):
They are the leading global, physician-led provider of integrated cancer care services.

This description is adapted from 21st Century Oncology prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as 21st Century Oncology "ICC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.